Active15417327Private limited companyAlderley Edge

DOMINION BIOTECH LTD

Significant control: Anthony Stephen Holmes (25–50%), Gareth Joseph Griffiths (25–50%)

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Dominion Biotech Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Dominion Biotech Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

DOMINION BIOTECH LTD is an active private limited company (company number 15417327) incorporated on 16 January 2024, registered in Alderley Edge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 January 2026, showing net assets of −£7,337, with 0 employees on average. Turnover was £120k and profit for the year −£7,082. Net assets fell 2777% on the prior period (−£255).

Peer position · net assets

By net assets it sits in the bottom quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).

Ownership and control

2 active · 1 other

AS
Dr Anthony Stephen Holmes
Individual · since 16 January 2024
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
25–50%
GJ
Dr Gareth Joseph Griffiths
Individual · since 28 March 2025
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
RS
Dr Roderick Simon Patrick Benson
Individual · since 16 January 2024 · ceased 28 March 2025
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
25–50%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 16 January 20242 yrs ago
Next accounts due: 31 October 2027in 370 days
Confirmation statement due: 30 January 2027in 96 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Micro Entity
Size band: MicroCompanies Act thresholds

Financials

2 periods on record · latest ending 31 January 2026

Net assets

−£7,337

vs Jan 2025

Cash at bank

Not reported

Turnover

£120k

Not reported the period before

Employees

vs Jan 2025

Net assets

−£7,337

Filed accounts by period, newest first
Period end	Net assets	Cash	Debtors	Creditors <1y	Turnover	Profit	Employees
31 January 2026	−£7,337	—	—	£93k	£120k	−£7,082	0
31 January 2025	−£255	—	—	£1,056	—	—	0

Current ratio0.84Current assets ÷ creditors within one year

Net margin-5.9%Profit for the year ÷ turnover

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.

Filing and accounts signals

Facts from the register · no rating

Net assets below zeroNet assets £-7,337 at 31 January 2026
Net assets down 25% or more on the prior period-2777.3% vs prior period
Current assets below creditors within one yearCurrent ratio 0.84
Incorporated two to five years agoIncorporated 16 January 2024

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

31 Oct 2027Next accounts duein 370 days
30 Jan 2027Confirmation statement duein 96 days
31 Jan 2026Accounts period endNet liabilities £7,337 · micro accounts
31 Jan 2025Accounts period endNet liabilities £255 · micro accounts
16 Jan 2024Incorporated

Similar companies in Manchester

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 16 January 2024 · in Jan 2024.

Reminders for DOMINION BIOTECH LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.